Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1842000
PUBLISHER: Grand View Research | PRODUCT CODE: 1842000
U.S. Antibody Specificity Testing Market Size, Share & Trends Analysis Report, By Product & Services, By Technology, By Application, By End-use, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Market Size & Trends:
The U.S. antibody specificity testing market size was estimated at USD 317.3 million in 2024 and is projected to reach USD 592.6 million by 2033, growing at a CAGR of 7.39% from 2025 to 2033. The market growth is driven by the rising use of antibody-based therapeutics and diagnostics, coupled with the growing focus on research reproducibility. Advancements in validation methods such as high-throughput screening and flow cytometry, along with strong U.S. research infrastructure and funding support, are expected to accelerate adoption further.
Growing disease burden
One of the major factors driving demand in the U.S. antibody specificity testing market is the growing disease burden, particularly the rising prevalence of cancer, autoimmune disorders, and infectious diseases. These conditions have significantly increased the reliance on antibody-based diagnostics and therapeutics, as antibodies play a crucial role in identifying disease biomarkers, monitoring disease progression, and developing targeted treatment approaches. With the U.S. witnessing a steady increase in chronic disease incidence, healthcare providers and researchers are placing greater emphasis on validating the accuracy and specificity of antibodies to ensure reliable diagnostic and therapeutic outcomes.
Moreover, the shift toward personalized and precision medicine has amplified the need for highly specific antibodies, as treatment strategies increasingly depend on biomarker-driven approaches. Antibody specificity testing enables the selection and validation of antibodies that can accurately target disease pathways without cross-reactivity, thereby improving patient outcomes and reducing risks of ineffective treatment. This growing demand for high-quality, validated antibodies supported by advances in testing technologies and strong U.S. R&D investment will remain a core driver of market expansion throughout the forecast period.
U.S. Antibody Specificity Testing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. antibody specificity testing market on the basis of product & services, technology, application, and end-use:
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Products
- Antibodies
- Control & Standards
- Kits & Reagents
- Gene Validation Tools
- Antibody Validation & Specificity Testing Services
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Immunoassay-based Technologies
- Western Blotting
- Immunochemistry
- Flow Cytometry
- Others
- Genetic Validation-based Technologies
- Microarray-based Antibody Technologies
- Other Technologies
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Research & Development
- Drug Discovery & Development
- Proteomics & Biomarker Discovery
- Clinical Diagnostics
- Infectious Diseases
- Oncology
- Immunology & Autoimmune Disorders
- Neurodegenerative Disorders
- Metabolic Disorders
- Others
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Other End Use
Product Code: GVR-4-68040-738-1
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Product & Services
- 1.1.2. Technology
- 1.1.3. Application
- 1.1.4. End Use
- 1.2. Market Definitions
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Others
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing disease burden
- 3.2.1.2. Advances in technologies
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Technical complexity and reproducibility challenges
- 3.2.2.2. High cost of advanced validation technologies
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
Chapter 4. Product & Services Business Analysis
- 4.1. Product & Services Segment Dashboard
- 4.2. U.S. Antibody Specificity Testing Market: Product & Services Movement Analysis
- 4.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
- 4.4. Products
- 4.4.1. Products Market, 2021 - 2033 (USD Million)
- 4.4.2. Antibodies
- 4.4.2.1. Antibodies Market, 2021 - 2033 (USD Million)
- 4.4.3. Control & Standards
- 4.4.3.1. Control & Standards Market, 2021 - 2033 (USD Million)
- 4.4.4. Kits & Reagents
- 4.4.4.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
- 4.4.5. Gene Validation Tools
- 4.4.5.1. Gene Validation Tools Market, 2021 - 2033 (USD Million)
- 4.5. Antibody Validation & Specificity Testing Services
- 4.5.1. Antibody Validation & Specificity Testing Services Market, 2021 - 2033 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Product & Services Segment Dashboard
- 5.2. U.S. Antibody Specificity Testing Market: Technology Movement Analysis
- 5.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
- 5.4. Immunoassay-based Technologies
- 5.4.1. Immunoassay-based Technologies Market, 2021 - 2033 (USD Million)
- 5.4.2. Western Blotting
- 5.4.2.1. Western Blotting Market, 2021 - 2033 (USD Million)
- 5.4.3. Immunochemistry
- 5.4.3.1. Immunochemistry Market, 2021 - 2033 (USD Million)
- 5.4.4. Flow Cytometry
- 5.4.4.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
- 5.4.5. Others
- 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
- 5.5. Genetic Validation-based Technologies
- 5.5.1. Genetic Validation-based Technologies Market, 2021 - 2033 (USD Million)
- 5.6. Microarray-based Antibody Technologies
- 5.6.1. Microarray-based Antibody Technologies Market, 2021 - 2033 (USD Million)
- 5.7. Other Technologies
- 5.7.1. Other Technologies Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. U.S. Antibody Specificity Testing Market: Application Movement Analysis
- 6.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Research & Development
- 6.4.1. Research & Development Market, 2021 - 2033 (USD Million)
- 6.4.2. Drug Discovery & Development
- 6.4.2.1. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
- 6.4.3. Proteomics & Biomarker Discovery
- 6.4.3.1. Proteomics & Biomarker Discovery Market, 2021 - 2033 (USD Million)
- 6.5. Clinical Diagnostics
- 6.5.1. Clinical Diagnostics Market, 2021 - 2033 (USD Million)
- 6.5.2. Infectious Diseases
- 6.5.2.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
- 6.5.3. Oncology
- 6.5.3.1. Oncology Market, 2021 - 2033 (USD Million)
- 6.5.4. Immunology & Autoimmune Disorders
- 6.5.4.1. Immunology & Autoimmune Disorders Market, 2021 - 2033 (USD Million)
- 6.5.5. Neurodegenerative Disorders
- 6.5.5.1. Neurodegenerative Disorders Market, 2021 - 2033 (USD Million)
- 6.5.6. Metabolic Disorders
- 6.5.6.1. Metabolic Disorders Market, 2021 - 2033 (USD Million)
- 6.5.7. Others
- 6.5.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
- 7.1. End Use Segment Dashboard
- 7.2. U.S. Antibody Specificity Testing Market: End Use Movement Analysis
- 7.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Pharmaceutical and Biotechnology Companies
- 7.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
- 7.5. Academic and Research Institutions
- 7.5.1. Academic and Research Institutions Market, 2021 - 2033 (USD Million)
- 7.6. Diagnostic Laboratories
- 7.6.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
- 7.7. Other End Use
- 7.7.1. Other End Use Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Danaher
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Bio-Rad Laboratories, Inc.
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Merck KGaA
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Cell Signaling Technology, Inc.
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. BD
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Novus Biologicals
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. OriGene Technologies, Inc.
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Creative Diagnostics
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. GenScript
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Danaher
Product Code: GVR-4-68040-738-1
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Regulatory Framework
- Table 4 U.S. Antibody Specificity Testing Market, By Product & Services, 2021 - 2033 (USD Million)
- Table 5 U.S. Antibody Specificity Testing Market, By Technology, 2021 - 2033 (USD Million)
- Table 6 U.S. Antibody Specificity Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 7 U.S. Antibody Specificity Testing Market, By End use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 U.S. antibody specificity testing market segmentation
- Fig. 8 Market snapshot, 2024
- Fig. 9 Market trends & outlook
- Fig. 10 Market driver relevance analysis
- Fig. 11 Market restraint relevance analysis
- Fig. 12 PESTEL analysis
- Fig. 13 Porter's five forces analysis
- Fig. 14 U.S. antibody specificity testing market: Product & services movement analysis
- Fig. 15 U.S. antibody specificity testing market, for product, 2021 - 2033 (USD Million)
- Fig. 16 U.S. antibody specificity testing market, for kits & reagents, 2021 - 2033 (USD Million)
- Fig. 17 U.S. antibody specificity testing market, for antibodies, 2021 - 2033 (USD Million)
- Fig. 18 U.S. antibody specificity testing market, for control & standards, 2021 - 2033 (USD Million)
- Fig. 19 U.S. antibody specificity testing market, for gene validation tools, 2021 - 2033 (USD Million)
- Fig. 20 U.S. antibody specificity testing market, for antibody validation & specificity testing services, 2021 - 2033 (USD Million)
- Fig. 21 U.S. antibody specificity testing market: Technology movement analysis
- Fig. 22 U.S. antibody specificity testing market, for immunoassay-based technologies, 2021 - 2033 (USD Million)
- Fig. 23 U.S. antibody specificity testing market, for western blotting, 2021 - 2033 (USD Million)
- Fig. 24 U.S. antibody specificity testing market, for immunochemistry, 2021 - 2033 (USD Million)
- Fig. 25 U.S. antibody specificity testing market, for flow cytometry, 2021 - 2033 (USD Million)
- Fig. 26 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
- Fig. 27 U.S. antibody specificity testing market, for genetic validation-based technologies, 2021 - 2033 (USD Million)
- Fig. 28 U.S. antibody specificity testing market, for microarray-based antibody technologies, 2021 - 2033 (USD Million)
- Fig. 29 U.S. antibody specificity testing market, for other technologies, 2021 - 2033 (USD Million)
- Fig. 30 U.S. antibody specificity testing market: Application movement analysis
- Fig. 31 U.S. antibody specificity testing market, for research and development, 2021 - 2033 (USD Million)
- Fig. 32 U.S. antibody specificity testing market, for drug discovery & development, 2021 - 2033 (USD Million)
- Fig. 33 U.S. antibody specificity testing market, for proteomics & biomarker discovery, 2021 - 2033 (USD Million)
- Fig. 34 U.S. antibody specificity testing market, for clinical diagnostics, 2021 - 2033 (USD Million)
- Fig. 35 U.S. antibody specificity testing market, for oncology, 2021 - 2033 (USD Million)
- Fig. 36 U.S. antibody specificity testing market, for infectious diseases, 2021 - 2033 (USD Million)
- Fig. 37 U.S. antibody specificity testing market, for immunology & autoimmune disorders, 2021 - 2033 (USD Million)
- Fig. 38 U.S. antibody specificity testing market, for neurodegenerative disorders, 2021 - 2033 (USD Million)
- Fig. 39 U.S. antibody specificity testing market, for metabolic disorders, 2021 - 2033 (USD Million)
- Fig. 40 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
- Fig. 41 U.S. antibody specificity testing market: End Use movement analysis
- Fig. 42 U.S. antibody specificity testing market, for academic and research institutions, 2021 - 2033 (USD Million)
- Fig. 43 U.S. antibody specificity testing market, for pharmaceutical and biotechnology companies, 2021 - 2033 (USD Million)
- Fig. 44 U.S. antibody specificity testing market, for diagnostic laboratories, 2021 - 2033 (USD Million)
- Fig. 45 U.S. antibody specificity testing market, for other end use, 2021 - 2033 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.